5th Forum:
Key Trends in US Biopharma/Medtech Investing
March 31, 2016
1:00 PM - 5:00 PM
Yale Club Manhattan, Trumbull Room
Program
1:00-1:30 PM Lunch and Networking
1:30-1:40 PM Opening Remarks
DoHyun Cho, PhD
CEO and President, W Medical Strategy Group / Chairman, New York Health Forum
1:40-2:20 PM Session 1
"Biopharma/ Medtech Funding
-
Joe McMenamin, MD, JD, Executive Vice President, WMSG (Moderator)
-
Katya Hancock, Director, Strategic Partnerships, StartUp Health
-
Sean Drake, Managing Director, Stony Lonesome Group LLC
2:20-3:00 PM Session 2
"The Key Factors to Raising Capital: What Will Attract Investors”
-
Kimberly Ha, Senior Director, FTI Consulting (Moderator)
-
Norman Yun, Managing Director, H.C Wainwright & Co.
-
Vincent Liu, PhD, Managing Director, Chief US Representative, Fosun Pharma
3:00-3:20 PM Networking Break
3:20-3:40 PM Award Ceremony (Awardees: Joe McMenamin and Kimberly Ha)
3:40-4:30 PM Session 3
“New Breed of Contributors: Alternative Biopharma/ Medtech”
-
Tony Chen, CEO, Primevax Immuno-Oncology, Inc (Moderator)
-
Frank Borchetta, CEO & Co-Founder, Repairogen Corporation
-
Imran Babar, PhD, Senior Associate, OrbiMed LLC
-
Karen Carr, Regional Development Officer, Gateway for Cancer Research
4:30 PM Closing